Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP was awarded a 3-year R18 grant through the Agency for Healthcare Research and Quality (AHRQ). Kane-Gill will conduct a cluster, randomized controlled trial to determine the impact of patient-centered telemedicine-based high-risk medication regimen reviews on adverse drug event (ADE) reduction in four nursing homes. In this study a new pharmacy practice model for consultant pharmacists will be developed and evaluated that includes more frequent medication regimen reviews when residents are prescribed high-risk drugs on admission and during their stay. The product of this research will be a generalizable electronic medical record-agnostic medication regimen review model including decision support rules, and structured communication tools to optimally execute the consultant pharmacist’s role in ADE prevention in the nursing home.
Kane-Gill is an associate professor in the pharmacy and therapeutics department at the School of Pharmacy.
